Boston Scientific profit beats estimates as cardiovascular sales surge
Sales of the Marlborough, Mass. company’s cardiovascular products rose 17.8% to $2.64 billion.
Sales of the Marlborough, Mass. company’s cardiovascular products rose 17.8% to $2.64 billion.
